Westlake Omics

Westlake Omics, established in July 2020, is committed to combining big data in proteomics with artificial intelligence. Based on mass spectrometry digital technology for biological samples, it develops new methods for auxiliary clinical diagnosis based on proteomics and other molecular omics, contributing to the precise auxiliary diagnosis of major human diseases such as cancer. Westlake Omics has gathered a high-quality team of more than 80 professionals with diverse academic backgrounds in biology, medicine, AI, and more. Currently, Westlake Omics has established collaborations with over a hundred well-known universities, research institutes, hospitals, and pharmaceutical companies both domestically and internationally, and owns multiple national patents and computer software copyrights.